When compared to other methods, AOD 9604 peptide outperforms them as it has selectively fat reducing properties which makes Stander approach again. The peptide stimulates lipolysis, breaking down stored fat more easily and therefore increasing fat metabolism. Proven in clinical studies to decrease body fat by 10-15% over a period of 12 weeks [1]
Reduced metabolic activity = energy in but decreased expenditure — not what you want, when your goal is trimming down the fatty tissues. 10 Interestingly enough, a clinical trial by the International Obesity Institute showed that people using AOD-9604 along w/a healthy diet and exercise program can lose up to twenty % more fat through increased lipid oxidation compared with those on placebo (control). One of those peptides is especially effective for the reduction of abdominal fat, which even daily running can struggle to target. In a study published in The Journal of Endocrinology, AOD 9604 increased lipase activity by up to 25%, an enzyme which plays a huge role in breaking down fat.
This peptide is known for its few side effects in comparison to other weight loss aids. The targeted action of the peptide allows for weight loss in an almost site specific way, bypassing muscle and Dr Jane Smith of the Global Obesity Institute believes, “AOD 9604 is targeted fat loss which when combined with lifestle changes should be very beneficial.”
In conclusion, AOD 9604 peptide treatment can significantly affect weight loss in humans and is linked with improvements of body composition; a feature that should make it an excellent therapeutic option for individuals looking for alternative to traditional methods of fat tissue management. Further information about the role of weight loss strategies in AOD 9604 peptide can be read here, which is supported by a large body of clinical evidence and results.